Follow

researchers used mRNA technology to develop an influenza vaccine that targets four proteins that tend to change little across viral strains.
the group describes their approach to developing new kind of flu vaccine and how well it has worked in test mice

medicalxpress.com/news/2022-11

Sign in to participate in the conversation

CounterSocial is the first Social Network Platform to take a zero-tolerance stance to hostile nations, bot accounts and trolls who are weaponizing OUR social media platforms and freedoms to engage in influence operations against us. And we're here to counter it.